These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

157 related articles for article (PubMed ID: 35039209)

  • 21. Foscarnet effective in acyclovir-resistant herpes.
    Am Pharm; 1991 Nov; NS31(11):12. PubMed ID: 1836936
    [No Abstract]   [Full Text] [Related]  

  • 22. Topical foscarnet for aciclovir-resistant mucocutaneous herpes infections in AIDS.
    Smith NA; Wood C; Asboe D; Bingham JS
    AIDS; 1997 Feb; 11(2):254-5. PubMed ID: 9030377
    [No Abstract]   [Full Text] [Related]  

  • 23. Genital herpes simplex infections in patients with the acquired immunodeficiency syndrome.
    McGrath BJ; Newman CL
    Pharmacotherapy; 1994; 14(5):529-42. PubMed ID: 7997387
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Pseudotumoral herpes genitalis in a woman living with HIV: Diagnosis and treatment challenges.
    Tomaino MV; Sanchez Costantini M; Alfaro CT
    Int J STD AIDS; 2024 Apr; 35(5):405-408. PubMed ID: 38031871
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Association of oral acyclovir and imiquimod for the treatment of hypertrophic genital herpes simplex in HIV positive patients: report of two cases.
    Barbosa Ldo N; Souto R; Furtado AL; Gripp AC; Daxbacher E
    An Bras Dermatol; 2011; 86(5):1043-5. PubMed ID: 22147057
    [TBL] [Abstract][Full Text] [Related]  

  • 26. A rapid screen test for in vitro susceptibility of clinical herpes simplex virus isolates.
    Safrin S; Elbeik T; Mills J
    J Infect Dis; 1994 Apr; 169(4):879-82. PubMed ID: 8133105
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Acyclovir-resistant herpes exulcerans et persistens. Type II].
    Klammer M; Kuhn A; Ruzicka T; Stege H
    Hautarzt; 2003 Apr; 54(4):362-4. PubMed ID: 12669211
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Intravenous foscarnet in the management of acyclovir-resistant herpes simplex virus type 2 in acute retinal necrosis in children.
    Khurana RN; Charonis A; Samuel MA; Gupta A; Tawansy KA
    Med Sci Monit; 2005 Dec; 11(12):CS75-8. PubMed ID: 16319793
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Atypical presentations of genital herpes simplex virus in HIV-1 and HIV-2 effectively treated by imiquimod.
    McKendry A; Narayana S; Browne R
    Int J STD AIDS; 2015 May; 26(6):441-3. PubMed ID: 24912536
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Successful treatment of progressive acyclovir-resistant herpes simplex virus using intravenous foscarnet in a patient with the acquired immunodeficiency syndrome.
    Sall RK; Kauffman CL; Levy CS
    Arch Dermatol; 1989 Nov; 125(11):1548-50. PubMed ID: 2554819
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Long-term follow-up of HIV-infected patients once diagnosed with acyclovir-resistant herpes simplex virus infection.
    Seang S; Boutolleau D; Burrel S; Regnier S; Epelboin L; Voujon D; Valantin MA; Katlama C; Agut H; Caumes E
    Int J STD AIDS; 2014 Aug; 25(9):676-82. PubMed ID: 24535691
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Foscarnet-resistant herpes simplex virus infection in patients with AIDS.
    Safrin S; Kemmerly S; Plotkin B; Smith T; Weissbach N; De Veranez D; Phan LD; Cohn D
    J Infect Dis; 1994 Jan; 169(1):193-6. PubMed ID: 8277181
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Foscarnet therapy for acyclovir-resistant mucocutaneous herpes simplex virus infection in 26 AIDS patients: preliminary data.
    Safrin S; Assaykeen T; Follansbee S; Mills J
    J Infect Dis; 1990 Jun; 161(6):1078-84. PubMed ID: 2161035
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Treatment of herpes simplex & varicella zoster infection.
    Barrg C; Sheehan G
    Ir Med J; 1996; 89(4):132-4. PubMed ID: 8824033
    [No Abstract]   [Full Text] [Related]  

  • 35. Successful foscarnet therapy for acyclovir-resistant mucocutaneous infection with herpes simplex virus in a recipient of allogeneic BMT.
    Verdonck LF; Cornelissen JJ; Smit J; Lepoutre J; de Gast GC; Dekker AW; Rozenberg-Arska M
    Bone Marrow Transplant; 1993 Feb; 11(2):177-9. PubMed ID: 8382096
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Treatment of acyclovir-resistant herpes simplex virus infections in patients with AIDS.
    Safrin S
    J Acquir Immune Defic Syndr (1988); 1992; 5 Suppl 1():S29-32. PubMed ID: 1602361
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [Resistance of herpes simplex viruses to antiviral drugs].
    Scieux C; Bianchi A
    Pathol Biol (Paris); 1993 Feb; 41(2):172-7. PubMed ID: 8392160
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Treatment of acyclovir-resistant, foscarnet-unresponsive HSV infection with topical cidofovir in a child with AIDS.
    Lateef F; Don PC; Kaufmann M; White SM; Weinberg JM
    Arch Dermatol; 1998 Sep; 134(9):1169-70. PubMed ID: 9762047
    [No Abstract]   [Full Text] [Related]  

  • 39. [Chronic herpes resistant to acyclovir in a patient with AIDS].
    About I; Capdeville J; Bernard P; Massip P
    Ann Dermatol Venereol; 1994; 121(11):810-3. PubMed ID: 7631991
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Topical trifluridine for mucocutaneous acyclovir-resistant herpes simplex II in AIDS patient.
    Murphy M; Morley A; Eglin RP; Monteiro E
    Lancet; 1992 Oct; 340(8826):1040. PubMed ID: 1357429
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.